PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 22, 2026Kidney3600 citationsOpen Access

When the Podocyte Speaks First: Anti-Nephrin Associated Diffuse Podocytopathy Preceding Hodgkin’s Lymphoma

View Full Paper
KKKrishna Mohita KuruvadaFGFady GriesAWArjun Wanchoo

Key Points

  • To explore the relationship between anti-nephrin positive minimal change disease and Hodgkin’s lymphoma.
  • Conducted kidney biopsy and immunostaining for diagnosis of minimal change disease.
  • Administered multiple immunosuppressive therapies due to relapses and steroid intolerance.
  • Monitored patient's clinical course and treatment outcomes over 18 months.
  • The patient experienced multiple relapses of minimal change disease despite ongoing treatments.
  • A diagnosis of Hodgkin’s lymphoma was made 18 months after the minimal change disease diagnosis.
  • Complete remission of both conditions was achieved following chemotherapy and radiation therapy.

Abstract

We report the case of a 23-year-old woman who developed minimal change disease (MCD) in the postpartum period. Kidney biopsy findings were consistent with MCD, with positive anti-nephrin immunostaining. Her clinical course was complicated by multiple relapses and steroid intolerance, requiring treatment with multiple immunosuppressive therapies. Despite therapy, complete remission was not achieved. A year and a half after the MCD diagnosis, she was diagnosed with Hodgkin’s lymphoma. Following chemotherapy and radiation therapy, the patient finally achieved complete remission of both MCD and Hodgkin’s lymphoma. This case highlights the complex relationship between MCD and lymphoproliferative disorders. It suggests that anti-nephrin positive MCD, typically considered a primary podocytopathy, may in rare instances represent a paraneoplastic manifestation. Additionally, this report highlights the importance of maintaining a high index of suspicion for occult malignancy in young patients with relapsing or refractory MCD, despite biomarkers suggesting primary disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kuruvada et al. (2026) studied this question.

synapsesocial.com/papers/69e865926e0dea528ddea197https://doi.org/10.34067/kid.0000001225
Ask AI
Helpful
Bookmark
Share
View Full Paper